These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2888152)

  • 1. Comparison of the effects of quazepam and triazolam on cognitive-neuromotor performance.
    Nikaido AM; Ellinwood EH
    Psychopharmacology (Berl); 1987; 92(4):459-64. PubMed ID: 2888152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A follow-up study of the acute behavioral effects of benzodiazepine-receptor ligands in humans: comparison of quazepam and triazolam.
    Rush CR; Ali JA
    Exp Clin Psychopharmacol; 1999 Aug; 7(3):257-65. PubMed ID: 10472514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzodiazepine-receptor ligands in humans: acute performance-impairing, subject-rated and observer-rated effects.
    Rush CR; Armstrong DL; Ali JA; Pazzaglia PJ
    J Clin Psychopharmacol; 1998 Apr; 18(2):154-65. PubMed ID: 9555600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerance and rebound during and after short-term administration of quazepam, triazolam and placebo to healthy human volunteers.
    Lee A; Lader M
    Int Clin Psychopharmacol; 1988 Jan; 3(1):31-47. PubMed ID: 2895786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).
    Saletu B; Anderer P; Brandstätter N; Frey R; Grünberger J; Klösch G; Mandl M; Wetter T; Zeitlhofer J
    Neuropsychobiology; 1994; 29(2):69-90. PubMed ID: 8170529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative affinity of quazepam for type-1 benzodiazepine receptors in brain.
    Wamsley JK; Hunt MA
    J Clin Psychiatry; 1991 Sep; 52 Suppl():15-20. PubMed ID: 1680119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative abuse liability of indiplon and triazolam in humans: a comparison of psychomotor, subjective, and cognitive effects.
    Carter LP; Griffiths RR; Suess PE; Casada JH; Wallace CL; Roache JD
    J Pharmacol Exp Ther; 2007 Aug; 322(2):749-59. PubMed ID: 17502431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between grapefruit juice and hypnotic drugs: comparison of triazolam and quazepam.
    Sugimoto K; Araki N; Ohmori M; Harada K; Cui Y; Tsuruoka S; Kawaguchi A; Fujimura A
    Eur J Clin Pharmacol; 2006 Mar; 62(3):209-15. PubMed ID: 16416305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory and sedative effects of triazolam in volunteers.
    Longbottom RT; Pleuvry BJ
    Br J Anaesth; 1984 Feb; 56(2):179-85. PubMed ID: 6140935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Midazolam and triazolam: hypnotic action and residual effects after a single bedtime dose.
    Borbély AA; Loepfe M; Mattmann P; Tobler I
    Arzneimittelforschung; 1983; 33(10):1500-2. PubMed ID: 6140018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quazepam. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in insomnia.
    Ankier SI; Goa KL
    Drugs; 1988 Jan; 35(1):42-62. PubMed ID: 2894293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zopiclone produces effects on human performance similar to flurazepam, lormetazepam and triazolam.
    Griffiths AN; Jones DM; Richens A
    Br J Clin Pharmacol; 1986 Jun; 21(6):647-53. PubMed ID: 2874822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of flurazepam and triazolam on neuropsychological performance.
    Bornstein RA; Watson GD; Kaplan MJ
    Percept Mot Skills; 1985 Feb; 60(1):47-52. PubMed ID: 2858842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zolpidem, triazolam, and temazepam: behavioral and subject-rated effects in normal volunteers.
    Rush CR; Griffiths RR
    J Clin Psychopharmacol; 1996 Apr; 16(2):146-57. PubMed ID: 8690830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal study on pharmacodynamics and pharmacokinetics of acute, steady-state and withdrawn quazepam.
    Schaffler K; Kauert G; Wauschkuhn CH; Klausnitzer W
    Arzneimittelforschung; 1989 Feb; 39(2):276-83. PubMed ID: 2567171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative cognitive and psychomotor effects of single doses of Valeriana officianalis and triazolam in healthy volunteers.
    Hallam KT; Olver JS; McGrath C; Norman TR
    Hum Psychopharmacol; 2003 Dec; 18(8):619-25. PubMed ID: 14696021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of triazolam and pentobarbital: performance impairment, subjective effects and abuse liability.
    Roache JD; Griffiths RR
    J Pharmacol Exp Ther; 1985 Jul; 234(1):120-33. PubMed ID: 2861282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperphagic and anorectic effects of beta-carbolines in a palatable food consumption test: comparisons with triazolam and quazepam.
    Cooper SJ
    Eur J Pharmacol; 1986 Jan; 120(3):257-65. PubMed ID: 3753939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability.
    Evans SM; Funderburk FR; Griffiths RR
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1246-55. PubMed ID: 2262904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of acute treatment with ramelteon, triazolam, and placebo on driving performance, cognitive function, and equilibrium function in healthy volunteers.
    Miyata A; Iwamoto K; Kawano N; Kohmura K; Yamamoto M; Aleksic B; Ebe K; Noda A; Noda Y; Iritani S; Ozaki N
    Psychopharmacology (Berl); 2015 Jun; 232(12):2127-37. PubMed ID: 25533998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.